• Corpus ID: 248496523

Mind the gap: how multiracial individuals get left behind when we talk about race, ethnicity, and ancestry in genomic research

  title={Mind the gap: how multiracial individuals get left behind when we talk about race, ethnicity, and ancestry in genomic research},
  author={Daphne Oluwaseun Martschenko and Hannah Wand and Jennifer L Young and Genevieve L. Wojcik Center for Biomedical Ethics and Stanford School of Medicine and Carrie Stanford and De Cardiology and Center for Individualized Medicine and Northwestern University and Feinberg School of Medicine and Il Chicago and Department of Epidemiology and Johns Hopkins Bloomberg School of Public Health and Baltimore.},
It is widely acknowledged that there is a diversity problem in genomics stemming from the vast underrepresentation of non-European genetic ancestry populations. While many challenges exist to address this gap, a major complicating factor is the misalignment between (1) how society defines and labels individuals; (2) how populations are defined for research; and (3) how research findings are translated to benefit human health. Recent conversations to address the lack of clarity in terminology in… 

Tables from this paper



Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: experiences from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program

This work offers commentary and concrete recommendations on the use and reporting of race, ethnicity, and ancestry across the arc of genetic research, including terminology, data harmonization, analysis, and reporting, broadly applicable to basic and translational genomic research in diverse populations.

Ambiguity and Scientific Authority: Population Classification in Genomic Science

The molecularization of race thesis suggests geneticists are gaining greater authority to define human populations and differences, and they are doing so by increasingly defining them in terms of

Racial and Ethnic Disparities in COVID-19 Outcomes: Social Determination of Health

Investigating pandemic disparities and examining some factors which inform the social determination of health finds that on a national level, Hispanic/Latinx, American Indian/Alaskan Native, Native Hawaiian/Pacific Islanders, and Black people are over-represented in COVID-19 incidence.

Genes, race, and culture in clinical care: racial profiling in the management of chronic illness.

It is concluded that using race in clinical medicine promotes and maintains the illusion of inherent racial differences and may result in minority patients receiving care aimed at presumed racial group characteristics, rather than care selected as specifically appropriate for them as individuals.

Clinical use of current polygenic risk scores may exacerbate health disparities

To realize the full and equitable potential of polygenic risk scores, greater diversity must be prioritized in genetic studies, and summary statistics must be publically disseminated to ensure that health disparities are not increased for those individuals already most underserved.

A review of multiracial malleability: Identity, categorization, and shifting racial attitudes

Soc Personal Psychol Compass. 2018;1–15. w Abstract The majority of social perception research to date has focused on perceptually obvious and prototypical representations of social categories.

The power of genetic diversity in genome-wide association studies of lipids.

A multi-ancestry, genome-wide genetic discovery meta-analysis of lipid levels in approximately 1.65 million individuals, including 350,000 of non-European ancestries, finds that increasing diversity rather than studying additional individuals of European ancestry results in substantial improvements in fine-mapping functional variants and portability of polygenic prediction.

Precision Medicine Needs to Think Outside the Box

It is argued that precision medicine continues to rely on the same forms of crude categorization it seeks to unsettle and until the scientific community creates inclusive solutions for individuals who fall outside or between existing population labels, precision medicine will continue to fall short in its aims.